Chyrok V[au] - Search Results

This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Save citations to file

Email citations

Add to Collections

Selection:

Create a new collection
Add to an existing collection

Name your collection:

Name must be less than 100 characters

Choose a collection:

Unable to load your collection due to an error
Please try again

Add to My Bibliography

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Results by year

Year	Number of Results
2019	2
2020	1
2022	0

2 results

Page of 1

Results by year

Page 1

AURIEL-PsO: a randomized, double-blind phase III equivalence trial to demonstrate the clinical similarity of the proposed biosimilar MSB11022 to reference adalimumab in patients with moderate-to-severe chronic plaque-type psoriasis.

Hercogová J, Papp KA, Chyrok V, Ullmann M, Vlachos P, Edwards CJ. Hercogová J, et al. Among authors: chyrok v. Br J Dermatol. 2020 Feb;182(2):316-326. doi: 10.1111/bjd.18220. Epub 2019 Sep 26. Br J Dermatol. 2020. PMID: 31206593 Free PMC article. Clinical Trial.

Safety of adalimumab biosimilar MSB11022 (acetate-buffered formulation) in patients with moderately-to-severely active rheumatoid arthritis.

Edwards CJ, Monnet J, Ullmann M, Vlachos P, Chyrok V, Ghori V. Edwards CJ, et al. Among authors: chyrok v. Clin Rheumatol. 2019 Dec;38(12):3381-3390. doi: 10.1007/s10067-019-04679-y. Epub 2019 Aug 8. Clin Rheumatol. 2019. PMID: 31396834 Clinical Trial.

Page of 1

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results